Navigation Links
Brin Foundation Donates $3 million to The Parkinson's Institute and Clinical Center
Date:8/27/2009

SUNNYVALE, Calif., Aug. 27 /PRNewswire-USNewswire/ -- The Parkinson's Institute and Clinical Center (PI) is very excited to announce the receipt of a $3 million challenge grant from the Brin Foundation as the lead gift in the PI's $15 million Capital Campaign - "A Campaign to Conquer Parkinson's Disease." The "Challenge" feature of the grant invites individuals, foundations and corporations to partner with the Brin Foundation in support of Parkinson's research.

"This capital campaign will allow us not only to continue cutting-edge research, but also to expand it dramatically, while at the same time ensuring that we will continue to deliver compassionate care of the highest quality to our patients. We are thrilled to be in a new expanded facility that makes all of this possible," said J. William Langston, MD, founder and CEO of The Parkinson's Institute.

"The generosity of the Brin Foundation is a cornerstone of our long range fundraising initiative, which provides both stability and critical growth potential for PI," says Jonathan Friedman, Director of Development at PI.

Irwin Helford, Board Chairman of PI and former CEO of Viking Office Products and retired Vice Chairman of Office Depot, expressed his delight at learning of the gift. "It's heartening to see a leader of the new generation of successful entrepreneurs is taking up the banner of promising research philanthropy. Anne and Sergey have set the bar at a high level. I hope that other leaders, who care about ending terrible disease, will follow their example."

A portion of the campaign is devoted to the capital improvements in the organization's new, expanded 60,000 square foot facilities - for advanced research labs and state-of-the-art equipment. Additional funds are being used to engage new talented scientific research staff. This will enable the Institute to greatly accelerate its efforts to find the causes and cure for Parkinson's disease, expand effective, highest quality patient care and to significantly expand clinical trials for new drugs to better treat patients with Parkinson's disease.

Approximately 1 million Americans are affected with Parkinson's disease (PD), a common neurodegenerative disease that causes a high degree of disability and adds financial burden for our health care system. It is estimated that the number of PD cases will double by the year 2030. There is a critical need for new, novel therapies that will prevent or even reverse progression of Parkinson's disease. This is a major priority research focus at the Institute.

About the Parkinson's Institute and Clinical Center

Founded in 1988, The Parkinson's Institute and Clinical Center (PI) is America's only independent non-profit organization that provides both basic and clinical research, clinical trials and a comprehensive movement disorder patient clinic for Parkinson's disease (PD) and related neurological movement disorders, all under one roof. Its mission is to find the causes, provide first class patient care and discover a cure.

For more information, please visit www.thepi.org or call 408.734.2800


'/>"/>
SOURCE Parkinson's Institute
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Celebrity Link to Type 1 Diabetes Further Connects the Juvenile Diabetes Research Foundations Georgia Chapter and Blue Cross and Blue Shield of Georgia
2. Larta Institute Wins National Science Foundation (NSF) Contract
3. Brain Tumor Foundation Hopeful That Patients Diagnoses, Quality of Life Will Improve
4. Dr. Michael Barry of MGH is New President of Foundation for Informed Medical Decision Making
5. Epilepsy Foundation Northwest to Hold Only-One-Of-Its-Kind Camp for Kids
6. William C. Moyers Appointed Vice President of Foundation Relations for Hazelden
7. Henry M. Jackson Foundation names fellowship award winners
8. Ellison Medical Foundation awards more than $1 million to mid-career scientists
9. Hospice Foundation of America Presents New Educational Webinar on Supporting People with Intellectual Disabilities through Illness, Grief and Loss
10. Rainn Wilson (Dwight on The Office) Joins Reply.com at Fundraiser for Mona Foundation
11. Tiger Woods, Camilo Villegas, Mike Weir and Notah Begay III Play at 2009 Notah Begay III Foundation Challenge Monday, August 24
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing ... their videos a whole new perspective by using the title layers in ProSlice ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: